Drug General Information
Drug ID	D0A5SA
Former ID	DNCL003785
Drug Name	TAK-272
Indication	Type 2 diabetes [ICD9: 250; ICD10:E11]		Phase 2	[525048]
Company	Takeda
Structure		Download 2D MOL
Target and Pathway
Target(s)	Renin, renal	Target Info	Modulator	[549203]
KEGG Pathway	Renin-angiotensin system
PathWhiz Pathway	Angiotensin Metabolism
Reactome	Metabolism of Angiotensinogen to Angiotensins
WikiPathways	ACE Inhibitor Pathway
	Metabolism of Angiotensinogen to Angiotensins
References
Ref 525048	ClinicalTrials.gov (NCT02332824) A Phase 2 Dose-finding Study of TAK-272 in Patients With Type 2 Diabetes Mellitus and Microalbuminuria. U.S. National Institutes of Health.
Ref 549203	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033655)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.